OXBOF (Oxford BioDynamics) Stock Based Compensation: $1.02 Mil (TTM As of Mar. 2026)


What is Oxford BioDynamics Stock Based Compensation?

Oxford BioDynamics OXBOF Stock Based Compensation is $1.02 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

Oxford BioDynamics's Stock Based Compensation for the six months ended in Mar. 2026 was $0.56 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $1.02 Mil.

Oxford BioDynamics Stock Based Compensation Related Terms

Oxford BioDynamics Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Oxford BioDynamics's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford BioDynamics Stock Based Compensation Chart

Oxford BioDynamics Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.45 0.41 0.68 0.68

Oxford BioDynamics Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.28 0.21 0.46 0.56

Oxford BioDynamics Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.02 Mil.

What does a Stock Based Compensation of $1.02 Mil mean?
Oxford BioDynamics (OXBOF) has a Stock Based Compensation of $1.02 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Oxford BioDynamics and its competitors.
Is Oxford BioDynamics' Stock Based Compensation too high?
Oxford BioDynamics' current Stock Based Compensation is $1.02 Mil.
How does Oxford BioDynamics' Stock Based Compensation compare to TMO and DHR?
Oxford BioDynamics' Stock Based Compensation of $1.02 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Diagnostics & Research company?
A good Stock Based Compensation depends on the Medical Diagnostics & Research industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Oxford BioDynamics and its competitors. Oxford BioDynamics's current Stock Based Compensation is $1.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioDynamics stock overvalued right now?
Oxford BioDynamics (OXBOF) has a current Stock Based Compensation of $1.02 Mil. The current Stock Based Compensation is $1.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Oxford BioDynamics (OXBOF), the current Stock Based Compensation is $1.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oxford BioDynamics Business Description

Other Exchanges OBD:UKLMQ:Germany
Address John Smith Drive, 3140 Rowan Place, Oxford Business Park South, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.